• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Aurobindo > September 08, 2009

      Aurobindo gets US, Swiss nod for two drugs

      Posted AtThehindubusinessline.com

      MUMBAI: Aurobindo Pharma on Thursday said it has received regulatory approval in the United States for making and marketing low-cost anti-infection drug Clindamycin Hydrochloride.

      Besides, the drug maker has also received the Swiss government's nod for the licence of Cefepime APL injection, used in the treatment of various diseases, including pneumonia and skin-related infections.

      The US Food and Drug Administration has given its final approval to the company for Clindamycin Hydrochloride Capsules in the strengths of 150 mg and 300 mg, Aurobindo Pharma said in a filing to the Bombay Stock Exchange (BSE).

      Clindamycin capsules are generic equivalent of Pharmacia & Upjohn Company's Cleocin Hydrochloride capsules. According to an estimate for the 12-months ending March 2009, the product has a market size of about $55 million.

      “The product will be launched shortly,” Aurobindo said. After this approval, the Indian firm now has a total 101 approvals from the US drug regulator, which includes 73 final approvals and 28 tentative.

      The Swiss regulatory approval for Cefepime injection is in the strengths of 1g and 2g. This is Aurobindo's second product approval from Swissmedic, the company said.

      September 08, 2009


      Share this Article!

    Back to top^